Rating History for Sage Therapeutics (SAGE) by Guggenheim

More Stocks Rated by Guggenheim | Latest Ratings for SAGE
Date Analyst Type Rating
(Past)		 PT
(Past)		 Start $
(End $)		 % Chg. Details
11/2/2021 Yatin Suneja Upgrade Buy
(Neutral)		 55.00
(N/A)		 42.37
(32.28)		 -23.81% Details